MedPath

Effect of Moringa Oleifera Leaves on Glycemic Control of Women With Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Dietary Supplement: Supplementation of Moringa oleifera leaf powder
Registration Number
NCT06517602
Lead Sponsor
University of Milan
Brief Summary

The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was:

- Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose?

Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control.

Participants had to:

* Take Moringa oleifera leaves daily or abstain from consuming Moringa for 3 months.

* Consistently take prescribed oral hypoglycemic agents

* Undergo clinical examinations and measurement of biochemical, metabolic and body composition parameters at the time of recruitment and at the end of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
52
Inclusion Criteria
  • Diagnosis of type 2 diabetes for at least 1 year
  • Absence of advanced retinopathy, terminal renal failure, active diabetic ulcers, amputations, and heart failure
  • Treatment with only oral hypoglycemic drugs.
Exclusion Criteria
  • Diagnosis of type 1 diabetes
  • Pregnancy or lactation
  • Treatment with insulin.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MoringaSupplementation of Moringa oleifera leaf powderThe experimental group received for 3 months a daily supplementation of 10g of Moringa oleifera leaf powder to consume within the two main meals.
Primary Outcome Measures
NameTimeMethod
Fasting glucoseFasting glucose was measured at recruitment and at the end of the study (three months)
Glycosylated hemoglobin (HbA1c)Glycosylated hemoglobin was measured at recruitment and at the end of the study (three months)
Secondary Outcome Measures
NameTimeMethod
Hip circumferenceHip circumference were measured at recruitment and at the end of the study (3 months)
BMIBMI were measured at recruitment and at the end of the study (3 months)
Waist circumferenceWaist circumference were measured at recruitment and at the end of the study (3 months)
% body fat% of body fat were measured at recruitment and at the end of the study (3 months)
Blood pressureSystolic and diastolic blood pressure were measured at recruitment and at the end of the study (3 months)

Systolic and diastolic blood pressure

Trial Locations

Locations (1)

Dispensaris of Edchedería, Bir Lehlu, Mahbes, and Farsia (Smara camp)

🇩🇿

Tindouf, Algeria

© Copyright 2025. All Rights Reserved by MedPath